scispace - formally typeset
M

Mihaela-Loredana Vlad

Researcher at Romanian Academy

Publications -  6
Citations -  75

Mihaela-Loredana Vlad is an academic researcher from Romanian Academy. The author has contributed to research in topics: Internal medicine & Immunology. The author has an hindex of 3, co-authored 3 publications receiving 38 citations.

Papers
More filters
Journal ArticleDOI

Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis

TL;DR: Collectively, HDAC inhibition reduced atherosclerotic lesion progression in ApoE−/− mice, possibly by intertwined mechanisms involving negative regulation of Nox expression and inflammation.
Journal ArticleDOI

Histone Acetyltransferase-Dependent Pathways Mediate Upregulation of NADPH Oxidase 5 in Human Macrophages under Inflammatory Conditions: A Potential Mechanism of Reactive Oxygen Species Overproduction in Atherosclerosis

TL;DR: The expression pattern of key histone acetyltransferase subtypes in human atherosclerosis is investigated to determine their role in mediating the upregulation of Nox5 in macrophages under inflammatory conditions and to suggest the existence of a new epigenetic mechanism underlying oxidative stress in Atherosclerosis.
Journal ArticleDOI

Detection of Vascular Reactive Oxygen Species in Experimental Atherosclerosis by High-Resolution Near-Infrared Fluorescence Imaging Using VCAM-1-Targeted Liposomes Entrapping a Fluorogenic Redox-Sensitive Probe.

TL;DR: In this article, the cell-impermeant ROS Brite™ 700 (RB700) probe that produces bright near-infrared fluorescence upon ROS oxidation was encapsulated into VCAM-1-targeted, sterically stabilized liposomes (VLp).
Journal ArticleDOI

Monocyte-derived macrophages mediate S100a8/A9-induced oxidative stress and inflammation in the ischemic myocardium

TL;DR: In this paper , the role of macrophages (Mac) as potential cellular effectors of S100A8/A9 in MI was investigated, and the authors found that the effect was suppressed by ABR-238901.
Journal ArticleDOI

VLA4-Enhanced Allogeneic Endothelial Progenitor Cell-Based Therapy Preserves the Aortic Valve Function in a Mouse Model of Dyslipidemia and Diabetes

TL;DR: The experiments show that genetically modified allogeneic EPCs might be a safe treatment option, with bioavailability in the desired target compartments and the ability to preserve aortic valve function in dyslipidemia and diabetes.